Wearable patch biosensor technology applications for in-hospital and remote patient monitoring are rapidly gaining traction as developers gain expertise. As predicted in 2017’s Connected Wearable Patches report, clinical applications of wearable patches are the primary market drivers, but once they are clinically proven, extended use outside the clinical settings is a logical next step. As early as 2015 studies indicated, wearable patches are more useful than traditional Holter monitors to track arrhythmia.

VitalConnect, Inc., a San Jose-based leader in wearable biosensors, announced that its VitalPatch biosensor and Vista Solution 2.0 now successfully monitor 22 unique arrhythmias and 11 vital signs. The VitalPatch biosensor measures single-lead EKG, heart rate, heart rate variability, respiratory rate, body or skin temperature, body posture, fall detection, and steps (activity). VitalConnect partnered with CorVitals for patient monitoring and heart rhythm analysis to diagnose cardiac arrhythmias, relying on its certified Independent Diagnostic Test Facility and arrhythmia reporting platform. With its additional monitoring capabilities, Vista Solution presents a comprehensive overview of patient health using the integrated National Early Warning Score (NEWS) standard. The NEWS helps physicians optimize patient treatment.

When companies with complementary technologies work together, the result can be a system that is more effective and useful than the separate components. In this case, the collected data is processed rapidly to give clinicians information that can guide their treatment decisions.